The COVAX programme has signed deals for hundreds of millions of doses to vaccinate people in poor and lower-middle income ...

A new Lyme disease vaccine made by Pfizer and Valneva could lower infection rates of the tick-borne illness, but federal ...

Since pharmaceutical companies Pfizer and Valneva announced positive results from their phase 3 trial of a vaccine to prevent ...

Vaccine maker's critics hope for new attorney general to reverse Pam Bondi's hostility to clinical trial whistleblower's ...

In recent days, analysts have repeatedly flagged ongoing competitive and pricing pressures on Pfizer’s key products, ...

EU Parliament erupts during a heated session on the Pfizer documents. Activist and author Naomi Wolf confronts European ...

After shedding expensive commercial infrastructure and pivoting to a partnership model, the company is now positioning its ...

A new vaccine from companies Pfizer and Valneva meant to prevent Lyme disease may be one step closer to approval.

Pfizer Inc PFE shares are trading lower on Tuesday after the company and its COVID-19 vaccine partner paused an updated-shot ...

Dr. Jay Bhattacharya objected to the study’s methodology, saying it gave an inaccurate picture of the vaccine’s benefits.

The acting CDC director cited concerns with the methodology, but the design has long been used to test vaccine effectiveness.

Although it's not generating tons of money from its COVID vaccine and pill anymore, the business is still doing well. There ...